
Enamine's REAL Space (REadily AccessibLe) is the world's largest make-on-demand compound collection for early-stage drug discovery. Built from Enamine's in-house parallel chemistry expertise, it provides a combinatorially generated universe of drug-like molecules that can be synthesized, ordered, and delivered to your lab. Synthesis is completed in 3–4 weeks with an average success rate of over 80%.
The current release features 94.5 billion drug-like structures that can be searched and ordered directly. Every retrieved compound is ready to order from Enamine and delivered to your lab.
The latest version of REAL Space is built on a continuously refined foundation of Enamine's in-house synthesis expertise. All results found using BioSolveIT's tools are ready to order directly from Enamine, with fast and reliable delivery to your lab.
All results found using BioSolveIT's tools are ready to order directly from Enamine, with fast and reliable delivery to your lab.
REAL Space is built entirely from Enamine's validated parallel synthesis protocols applied to in-stock building blocks. Every virtual product reflects chemistry that Enamine can perform at scale, ensuring a direct path from in silico hit to orderable compound.
Since its first public release, REAL Space has grown by nearly three orders of magnitude, from 120 million compounds to over 94 billion today. The table below traces that growth across every documented release.
| Release | Compounds | Scale |
|---|---|---|
| ZINC15 | 120 M | |
| 2018-Q1 | 650 M | |
| 2018-Q2 | 3.8 B | |
| 2018-Q4 | 3.7 B | |
| 2019-Q1 | 5.1 B | |
| 2019-Q2 | 11 B | |
| 2019-Q4 | 13 B | |
| ZINC20 | 1.8 B | |
| 2020-Q2 | 14 B | |
| 2020-Q4 | 16 B | |
| 2021-Q1 | 18 B | |
| 2021-Q2 | 19 B | |
| 2021-Q3 | 20 B | |
| 2021-Q4 | 21 B | |
| ZINC22 | 37 B | |
| 2022-Q1 | 23 B | |
| 2022-Q2 | 29 B | |
| 2022-Q3 | 32 B | |
| 2022-Q4 | 34 B | |
| 2023-Q1 | 36 B | |
| 2023-Q2 | 36 B | |
| 2023-Q3 | 44 B | |
| 2023-Q4 | 48 B | |
| 2024-Q1 | 48 B | |
| 2024-Q3 | 70 B | |
| 2025-Q1 | 76 B | |
| 2025-Q3 | 83 B | |
| 2026-Q2 | 95 B | |
| Current ★ | 94.5 B |
★ Current release per enamine.net. ZINC15, ZINC20, and ZINC22 entries reflect independently curated REAL compound subsets made available through ZINC.
REAL Space can be conveniently explored using BioSolveIT's Chemical Space navigation platform, infiniSee. Over 94 billion entries can be searched for relevant chemistry within seconds to minutes on standard hardware. Various search algorithms are available to identify the best matches for the objectives of a drug discovery project.
Of course, REAL Space can also be accessed using the corresponding command-line versions of the modes (FTrees, SpaceLight, SpaceMACS).
Chemical Space Docking™ also enables structure-based screening of REAL Space within your target of interest. Executed within our drug design dashboard SeeSAR, molecules forming the most favorable interactions in the binding site can be efficiently mined on standard hardware, and without a connection to the internet.
This allows in-house projects to be streamlined without the involvement of third parties; you will work in a user-friendly environment with full control over your results.